Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EMA recommends Idefirix (imlinfidase) is granted marketing authorisation

europeanpharmaceuticalreviewJuly 03, 2020

Tag: EMA , Idefirix , Kidney transplant

PharmaSources Customer Service